The company’s consolidated profit rose to 1.35 billion rupees ($16 million) for the quarter ended June 30, while revenue rose 5 per cent to 15.62 billion rupees.
News
Indian drugmaker Alembic Pharma posts Q1 profit rise on strong US sales
August 9, 2024The company’s consolidated profit rose to 1.35 billion rupees ($16 million) for the quarter ended June 30, while revenue rose 5 per cent to 15.62 billion rupees.